Format

Send to

Choose Destination
Genet Med. 2017 Aug;19(8):955-958. doi: 10.1038/gim.2016.206. Epub 2017 Jan 26.

Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma.

Author information

1
Sarcoma Department, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
2
Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
3
Cancer Genetics Services, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.

Abstract

PURPOSE:

Ewing sarcoma is a small round blue cell tumor that is highly malignant and predominantly affects the adolescent and young adult population. It has long been suspected that a genetic predisposition exists for this cancer, but the germ-line genetic underpinnings of this disease have not been well established.

METHODS:

We performed germline variant analysis of whole-genome or whole-exome sequencing of samples from 175 patients affected by Ewing sarcoma.

RESULTS:

We discovered pathogenic or likely pathogenic germline mutations in 13.1% of our cohort. Pathogenic mutations were highly enriched for genes involved with DNA damage repair and for genes associated with cancer predisposition syndromes.

CONCLUSION:

Our findings reported here have important clinical implications for patients and families affected by Ewing sarcoma. Genetic counseling should be considered for patients and families affected by this disease to take advantage of existing risk management strategies. Our study also highlights the importance of germline sequencing for patients enrolled in precision-medicine protocols.Genet Med advance online publication 26 January 2017.

PMID:
28125078
PMCID:
PMC5529247
DOI:
10.1038/gim.2016.206
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center